List of works - Abdel Kareem Azab

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

scientific article published on April 2013

BM mesenchymal stromal cell–derived exosomes facilitatemultiple myeloma progression

scientific article

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

scientific article

CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia

scientific article published on 01 October 2019

Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia.

scientific article published on 25 February 2011

Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia

scientific article

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.

scientific article

Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia

scientific article published on 18 October 2011

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

scientific article published on 13 July 2012

Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.

scientific article published on 9 October 2012

Molecularly targeted therapies in multiple myeloma

scientific article published on 16 April 2014

Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.

scientific article published on 16 February 2017

Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma

scientific article

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma

scientific article published on 04 October 2019

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

scientific article

Role of proteasome inhibition in Waldenström's macroglobulinemia.

scientific article published on March 2009

Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia

scientific article published on 28 January 2010

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib

scientific article

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy

scientific article published on 07 August 2019

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

scientific article published on 27 November 2020

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia

scientific article

List of works by Abdel Kareem Azab

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

BM mesenchymal stromal cell–derived exosomes facilitatemultiple myeloma progression

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia

Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia.

Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenstrom's macroglobulinemia

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.

Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.

Molecularly targeted therapies in multiple myeloma

Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.

Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Role of proteasome inhibition in Waldenström's macroglobulinemia.

Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia